Biological Intellectual Property Protection Act of 2025
United States119th CongressHR-6624House of Representatives
Updated: Apr 22, 2026
Summary
The bill establishes a Sense of Congress that the People's Republic of China (PRC) systematically exploits sensitive United States data and intellectual property to modernize its military and intelligence capabilities, enable human rights abuses, and develop dual-use technologies. It highlights the PRC's military-civil fusion strategy and laws compelling citizens to cooperate with national security, posing grave threats to U.S. national security. The export of novel synthetic DNA and RNA sequences is identified as a high potential for intellectual property theft by foreign adversaries, necessitating export controls. To address these concerns, the legislation amends the Export Control Reform Act of 2018 to require a license for the export, reexport, or in-country transfer of digital sequences of synthetic DNA or RNA to a foreign entity of concern . This requirement applies to sequences designed by humans or artificial intelligence systems. A "foreign entity of concern" includes government entities, foreign persons subject to or organized under the laws of a foreign country of concern, or those owned, directed, or controlled by such entities. The bill defines "digital sequence" as a binary file representing DNA/RNA identity and order, and "synthetic DNA or RNA" to include recombinant nucleic acids and chemically synthesized or modified nucleic acid molecules.
Bill texts
All available records shown.
Timeline
Latest companion bill action
S-3452: Biological Intellectual Property Protection Act of 2025Introduced in Senate
Introduced in House
Referred to the House Committee on Foreign Affairs.
House of Representatives
Committee Consideration and Mark-up Session Held
House of Representatives
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 30 - 14.
House of Representatives
All available records shown.